By Arun AgrahriLast reviewed 1 timecoded source
Short answer
Only a few peptides, such as PT-141 and tesamorelin, are FDA-approved drugs. On gray-market vials, three credited sources on tape lean toward the same warning, with none against: they lack human safety data and carry real contamination risk. Unregulated vials often skip the cleaning that removes LPS (endotoxin), which sets off an immune response, and may hold the wrong peptide.
Therapeutic peptides such as BPC-157 speed healing and recovery in people.
The verdict on Peptides overall. 5 sources: 3 positive, 1 partly, 1 negative
positive partly neutral negative Each researcher and each study counts once per claim, however often they come up.
Gray-market research peptides lack human safety data and carry real contamination risk.
4 sources: 2 positive, 2 partly.
Researchers say
1 positive, 2 partly
Abu Bakri, on Huberman Lab, at 2:42:31
Positive Video · Opinion
Open the tape at 2:42:31 →“the majority of people are getting their peptides from research only websites. Uh unfortunately those are not reliable. We don't know what's in them.”
Dr. Craig Koniver, on Huberman Lab, at 1:37:01
Partly Video · Opinion
Open the tape at 1:37:01 →“maybe they just throw some melatonin in there and call it pinin like there there's a lot of like BS stuff out there”
Andrew Huberman, on Huberman Lab, at 02:43
Partly Video · Opinion
Open the tape at 02:43 →“you can purchase them online but the safety and efficacy of those peptides is a bit questionable in some cases very questionable”
Studies show
1 positive
1 paper we read
Systematic review, Acta Orthop Belg, 2026, PMID 42885452
Positive Study
Read the paper on PubMed →The current literature on BPC-157 in humans is sparse (n=3), of poor quality, and of very low certainty overall.
Abu Bakri, on Huberman Lab, at 2:42:31 Video · positive · Opinion
“the majority of people are getting their peptides from research only websites. Uh unfortunately those are not reliable. We don't know what's in them.”
Systematic review, Acta Orthop Belg, 2026, PMID 42885452 Study · positive
The current literature on BPC-157 in humans is sparse (n=3), of poor quality, and of very low certainty overall.
Dr. Craig Koniver, on Huberman Lab, at 1:37:01 Video · partly · Opinion
“maybe they just throw some melatonin in there and call it pinin like there there's a lot of like BS stuff out there”
Andrew Huberman, on Huberman Lab, at 02:43 Video · partly · Opinion
“you can purchase them online but the safety and efficacy of those peptides is a bit questionable in some cases very questionable”
Gray-market research peptides lack human safety data and carry real contamination risk.
Researchers
Abu Bakri, on Huberman Lab, at 2:42:31
Positive Video · Opinion
Open the tape at 2:42:31 →“the majority of people are getting their peptides from research only websites. Uh unfortunately those are not reliable. We don't know what's in them.”
Studies
Systematic review, Acta Orthop Belg, 2026, PMID 42885452
Positive Study
Read the paper on PubMed →The current literature on BPC-157 in humans is sparse (n=3), of poor quality, and of very low certainty overall.
Dr. Craig Koniver, on Huberman Lab, at 1:37:01
Partly Video · Opinion
Open the tape at 1:37:01 →“maybe they just throw some melatonin in there and call it pinin like there there's a lot of like BS stuff out there”
Andrew Huberman, on Huberman Lab, at 02:43
Partly Video · Opinion
Open the tape at 02:43 →“you can purchase them online but the safety and efficacy of those peptides is a bit questionable in some cases very questionable”
Precis is not affiliated with or endorsed by YouTube or by any researcher, show or publisher we quote. We take no sponsorship, ad or affiliate money, and every verdict is our own review of what was said. How we stay independent
Three credited sources on tape count toward this claim: two physicians interviewed on Andrew Huberman's show, and Huberman on his own. None argues against it, though two back it only in part. Precis has read no studies on it yet, so the verdict rests on the tape.
Huberman sorts peptides into three groups. Tier 1 is prescription peptides the FDA has approved. PT-141 (Vyleesi) treats low sexual desire in premenopausal women, and tesamorelin reduces visceral fat, the fat around the organs, in HIV patients.
Tier 2 is the gray market, peptides sold online. Their safety and efficacy is "a bit questionable in some cases very questionable," he says. Tier 3 is the black market, where he says many products are contaminated or not what the label claims.
He advises a board-certified physician and a drug company or compounding pharmacy that removes LPS.
LPS (lipopolysaccharide, also called endotoxin) can build up when peptides are made. Prescription sources clean it out. Gray-market and black-market sources often don't, Huberman says. A tiny amount may not cause a big immune response, but many exposures can add up.
The physician on Huberman's peptide episode says most people buy from research-only websites. "We don't know what's in them," he says; the vial could even hold the wrong peptide. Craig Koniver, a physician on another Huberman episode, warns of vials that hold something else, such as melatonin sold as a peptide.
Huberman says BPC-157 raises VEGF, a growth signal for new blood vessels, the opposite of what a common cancer drug does. Anyone concerned about tumors or cancer, he says, should probably not explore it. BPC-157's LD50 in animals, the dose that kills half of them, is very high, but he stresses that this does not make high doses safe.
Peptides that raise growth hormone, such as CJC-1295, tesamorelin or MK-677, raise tumor and cancer risk, he says. MK-677 and similar compounds also cause big increases in cortisol.
The physician guest says the FDA moved BPC-157 onto its Category 2 list, which tells compounding pharmacies not to make it. It later came off that list but had not yet been cleared for doctors to prescribe through compounding.
Twenty-five more mentions are uncounted, about half of them host remarks inside interviews. In one, on Huberman's episode with Kyle Gillett, the speaker says labs use LPS on purpose to cause fever and inflammation, and that many people feel a mild fever or tingling after injecting. Precis has read no test of what research-only vials contain.
Precis membership
The answer above is the whole answer: the verdict, every counted mention, where the sources disagree, and the receipt behind each one. Nothing on this page is held back.
A free account adds
Pro adds
Full Peptides evidence report
The verdict on every claim, and where the sources disagree